-
05/22/2022
Athletic Brewing is a Certified B Corporation™
Certified B Corporations™ (B Corps) are businesses that meet the highest standards of social and environmental performance, public transparency, and legal accountability to balance profit and purpose. It is a tool to drive positive change...
Read More -
05/17/2022
Brex CEO breaks down how the fintech company disrupts corporate finances
Henrique Dubugras, co-founder and co-CEO of Brex, a disrupting corporate fintech company, joins CNBC’s ‘Squawk Box’ after being ranked number two on CNBC’s 10th annual Disruptor 50 list. CNBC has the complete footage for your...
Read More -
05/03/2022
OneDigital Partners With Rightway on Care Navigation Solution
OneDigital, a leading insurance brokerage, financial services and HR consulting firm, today announced an expanded partnership with Rightway, a leading care navigation provider. The expanded partnership will focus on delivering an enhanced clinical navigation solution,...
Read More -
04/05/2022
The New Rules of Après-Ski
If there’s one thing skiers love almost as much as being on the hill, it’s après-ski. The French term translates directly to “after skiing,” but a loose, and perhaps more accurate, translation is “hitting the...
Read More -
03/30/2022
Athletic Brewing Company – TIME100 Most Influential Companies of 2022
Founded in 2017, Athletic Brewing sold more than 100,000 barrels of beer last year (up from 37,500 in 2020) and was named 2021’s craft brewery of the year by trade publication Brewbound. The brand also...
Read More -
03/29/2022
Angiocrine Bioscience Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of AB-205 in Patients with Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (E-CELERATE) and Completion of Series B Financing
Angiocrine Bioscience, Inc., a clinical-stage biopharmaceutical company, today announced that the first patient has been dosed in its Phase 3 registration study AB-205-301 (E-CELERATE), a multi-center, randomized, double-blind, placebo-controlled study of AB-205 in adults with...
Read More -
03/08/2022
The 10 most innovative biotech companies in 2022
Explore the full 2022 list of Fast Company’s Most Innovative Companies, 528 organizations whose efforts are reshaping their businesses, industries, and the broader culture. We’ve selected the firms making the biggest impact with their initiatives...
Read More -
Athletic Brewing Trims the Carbs and Calories for Its First Light Non-Alcoholic Beer
Athletic Brewing Company, a leader in non-alcoholic craft beer, wraps several trends into one March Madness-themed campaign that launches its first-ever “light” product and draws in standout college players and an ESPN broadcaster as brand...
Read More -
No-Alcohol Leader Athletic Brewing Launches Newest Category Innovation: Lite Beer
Athletic Brewing, a leader in the non-alcoholic beer space, is rolling out a light beer — crisp. quaffable, and light at just 25 calories and 5 carbs (plus zero hangover, as the brand declares). The...
Read More -
03/01/2022
NextRNA Launches with $56 Million in Funding to Bring Transformative Non-Coding RNA-Directed Medicines to Patients
NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop transformative therapeutics, today announces its launch with $9.3 million in seed financing and a $46.8 million Series A led by Cobro Ventures...
Read More -
Takeda, Dana-Farber scientists team up on RNA startup
A former head at Takeda’s Center for External Innovation and a researcher at the Dana-Farber Cancer Institute have joined forces to launch NextRNA Therapeutics, a startup that aims to harness the potential of non-coding RNAs...
Read More -
02/22/2022
Dyslexic To Disruptor: Frequency Therapeutics CEO David Lucchino Is Working To Reverse Hearing Loss
For the last couple of years, all attention has turned to Covid-19 and vaccinations—and for obvious reasons. Now that we are hopefully getting close to the end of the pandemic, it’s time to look into...
Read More
